Hepatic microRNA orchestra: A new diagnostic, P.ognostic and theranostic tool for hepatocarcinogenesis

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 10, 2014, Pages 837-852

  Boye, Alex ^a,b   Yang, Yan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CAPE COAST   (Ghana)

Author keywords

Hepatocarcinogenesis; MAP; MicroRNA Therapeutics; Smad; TGF

Indexed keywords

ALPHA FETOPROTEIN; BIM PROTEIN; CYCLIN D1; DICER; EPIDERMAL GROWTH FACTOR; EXPORTIN 5; FIBROBLAST GROWTH FACTOR; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN; MICRORNA; MICRORNA 101; MICRORNA 122; MICRORNA 221; MICRORNA 25; MICRORNA 29; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN MCL 1; PROTEIN P53; RAN PROTEIN; RNA HELICASE; SCATTER FACTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BIOGENESIS; CANCER PROGNOSIS; CELL CYCLE REGULATION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LIVER CARCINOGENESIS; NEOPLASTIC TRANSFORMATION; NONHUMAN; ONCOGENE C MYC; PROTEIN ANALYSIS; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; MICRORNAS; PROGNOSIS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84911387174     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: None     Document Type: Article

References (168)

1. Davis, B.N.; Hilyard, A.C.; Lagna, G.; Hata, A., SMAD proteins control DROSHA-mediated microRNA maturation. Nature, 2008, 454, (7200), 56-61.
2. Lee, Y.; Kim, M.; Han, J.; Yeom, K.H.; Lee, S.; Baek, S.H.; Kim, V.N., MicroRNA genes are transcribed by RNA polymerase II. The EMBO J., 2004, 23, (20), 4051-4060.
3. Asirvatham, A.J.; Magner, W.J.; Tomasi, T.B., miRNA regulation of cytokine genes. Cytokine, 2009, 45, (2), 58-69.
4. Bartel, D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 2004, 116, (2), 281-297.
5. Lee, R.C.; Feinbaum, R.L.; Ambros, V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75 (5), 843-854.
6. Wightman, B.; Ha, I.; Ruvkun, G., P.sttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 1993, 755, 855-862.
7. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T., Identification of novel genes coding for small expressed RNAs. Science, 2001, 294, (5543), 853-858.
8. Lau, N.C.; Lim, L.P.; Weinstein, E.G.; Bartel, D.P., An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 2001, 294, (5543), 858-862.
9. Lee, R.C.; Ambros, V., An extensive class of small RNAs in Caenorhabditis elegans. Science, 2001, 294, (5543), 862-864.
10. Hata, A.; Davis, B.N., Control of microRNA biogenesis by TGFβ signaling pathway—a novel role of Smads in the nucleus. Cytokine & growth factor reviews, 2009, 20, (5), 517-521.
11. Lu, J.; Getz, G.; Miska, E.A.; Alvarez-Saavedra, E.; Lamb, J.; P.ck, D.; Sweet-Cordero, A.; Ebert, B.L.; Mak, R.H.; Ferrando, A.A., MicroRNA expression profiles classify human cancers. Nature, 2005, 435, (7043), 834-838.
12. Volinia, S.; Calin, G.A.; Liu, C.-G.; Ambs, S.; Cimmino, A.; P.trocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M., A microRNA expression signature of human solid tumors defines cancer gene targets. P.oceed. Nat Acad. Sci. U.S.A., 2006, 103, (7), 2257-2261.
13. Esteller, M., Non-coding RNAs in human disease. Nat. Rev. Genet., 2011, 12, (12), 861-874.
14. Calin, G.A.; Croce, C.M., MicroRNA signatures in human cancers. Nat. Rev. Cancer, 2006, 6, (11), 857-866.
15. Ambros, V., MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell, 2003, 113, (6), 673-676.
16. Croce, C.M., Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 2009, 10, (10), 704-714.
17. Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J.L.; Bradley, A., Identification of mammalian microRNA host genes and transcription units. Gen. Res., 2004, 14, (10a), 1902-1910.
18. Wang, X.W.; Heegaard, N.H.; Ørum, H., MicroRNAs in liver disease. Gastroenterology, 2012, 142, (7), 1431-1443.
19. Varnholt, H.; Drebber, U.; Schulze, F.; Wedemeyer, I.; Schirmacher, P.; Dienes, H.-P.; Odenthal, M., MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology, 2008, 47, (4), 1223-1232.
20. Mott, J.L., MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia. Hepatology, 2009, 50, (2), 630-637.
21. Murakami, Y.; Yasuda, T.; Saigo, K.; Urashima, T.; Toyoda, H.; Okanoue, T.; Shimotohno, K., Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 2006, 25, (17), 2537-2545.
22. Sun, J.; Lu, H.; Wang, X.; Jin, H., MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. Sci. World J., 2013, 2013.
23. Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S.T.; P.tel, T., MicroRNA-21 regulates expression of the P.EN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007, 133, (2), 647-658.
24. Gramantieri, L.; Ferracin, M.; Fornari, F.; Veronese, A.; Sabbioni, S.; Liu, C.-G.; Calin, G.A.; Giovannini, C.; Ferrazzi, E.; Grazi, G.L., Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res., 2007, 67, (13), 6092-6099.
25. Varnholt, H.; Drebber, U.; Schulze, F.; Wedemeyer, I.; Schirmacher, P.; Dienes, H.P.; Odenthal, M., MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology, 2008, 47, (4), 1223-1232.
26. Law, P.T.Y.; Wong, N., Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J. Gastroenterol. Hepatol., 2011, 26, (3), 437-449.
27. Braun, J.E.; Huntzinger, E.; Izaurralde, E., A molecular link between miRISCs and deadenylases provides new insight into the mechanism of gene silencing by microRNAs. Cold Spring Harbor P.rspect. Biol., 2012, 4, (12), a012328.
28. Lytle, J.R.; Yario, T.A.; Steitz, J.A., Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. P.oceed. Nat Acad. Sci. U.S.A., 2007, 104, (23), 9667-9672.
29. Filipowicz, W.; Bhattacharyya, S.N.; Sonenberg, N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet., 2008, 9, (2), 102-114.
30. Gregory, R.I.; Yan, K.-p.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R., The Microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 432, (7014), 235-240.
31. Shiohama, A.; Sasaki, T.; Noda, S.; Minoshima, S.; Shimizu, N., Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Experiment. Cell Res., 2007, 313, (20), 4196-4207.
32. Jiang, J.; Gusev, Y.; Aderca, I.; Mettler, T.A.; Nagorney, D.M.; Brackett, D.J.; Roberts, L.R.; Schmittgen, T.D., Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res., 2008, 14, (2), 419-427.
33. Yau, T.-O.; Chan, C.-Y.; Chan, K.-L.; Lee, M.-F.; Wong, C.-M.; Fan, S.-T.; Ng, I.O.-L., HDP.1, a novel inhibitor of the WNT/β-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Oncogene, 2004, 24, (9), 1607-1614.
34. Monga, S.P.S., Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int. J. Biochem. Cell Biol., 2011, 43, (7), 1021-1029.
35. Whittaker, S.; Marais, R.; Zhu, A., The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene, 2010, 29, (36), 4989-5005.
36. Lu, Z.; Liu, M.; Stribinskis, V.; Klinge, C.; Ramos, K.; Colburn, N.; Li, Y., MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 2008, 27, (31), 4373-4379.
37. Yoon, S.; Kim, T.H.; Natarajan, A.; Wang, S.S.; Choi, J.; Wu, J.; Zern, M.A.; Venugopal, S.K., Acute liver injury upregulates microRNA-491-5p in mice, and its overexpression sensitizes Hep G2 cells for tumour necrosis factor-α-induced apoptosis. Liver International, 2010, 30, (3), 376-387.
38. Li, N.; Fu, H.; Tie, Y.; Hu, Z.; Kong, W.; Wu, Y.; Zheng, X., miR- 34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett., 2009, 275, (1), 44-53.
39. Hand, N.J.; Master, Z.R.; Le Lay, J.; Friedman, J.R., Hepatic function is preserved in the absence of mature microRNAs. Hepatology, 2009, 49, (2), 618-626.
40. Mendell, J.T., miRiad roles for the miR-17-92 cluster in development and disease. Cell, 2008, 133, (2), 217-222.
41. Ivanovska, I.; Ball, A.S.; Diaz, R.L.; Magnus, J.F.; Kibukawa, M.; Schelter, J.M.; Kobayashi, S.V.; Lim, L.; Burchard, J.; Jackson, A.L., MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol., 2008, 28, (7), 2167-2174.
42. Fornari, F.; Gramantieri, L.; Ferracin, M.; Veronese, A.; Sabbioni, S.; Calin, G.; Grazi, G.; Giovannini, C.; Croce, C.; Bolondi, L., MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene, 2008, 27, (43), 5651-5661.
43. Li, R.; Zhu, H.; Ruan, J.; Qian, W.; Fang, X.; Shi, Z.; Li, Y.; Li, S.; Shan, G.; Kristiansen, K., De novo assembly of human genomes with massively parallel short read sequencing. Genome Res., 2010, 20, (2), 265-272.
44. Kang, W.; Tong, J.H.; Chan, A.W.; Lung, R.W.; Chau, S.L.; Wong, Q.W.; Wong, N.; Yu, J.; Cheng, A.S.; To, K.F., Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. P.oS One, 2012, 7, (3), e33919.
45. Kota, J.; Chivukula, R.R.; O'Donnell, K.A.; Wentzel, E.A.; Montgomery, C.L.; Hwang, H.-W.; Chang, T.-C.; Vivekanandan, P.; Torbenson, M.; Clark, K.R., Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 2009, 137, (6), 1005-1017.
46. Frankel, L.B.; Christoffersen, N.R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A.H., P.ogrammed cell death 4 (P.CD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 2008, 283, (2), 1026-1033.
47. Zhu, S.; Wu, H.; Wu, F.; Nie, D.; Sheng, S.; Mo, Y.-Y., MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res., 2008, 18, (3), 350-359.
48. Li, J.; Fu, H.; Xu, C.; Tie, Y.; Xing, R.; Zhu, J.; Qin, Y.; Sun, Z.; Zheng, X., miR-183 inhibits TGF-β1-induced apoptosis by downregulation of P.CD4 expression in human hepatocellular carcinoma cells. BMC Cancer, 2010, 10, (1), 354.
49. Talotta, F.; Cimmino, A.; Matarazzo, M.; Casalino, L.; De Vita, G.; D'Esposito, M.; Di Lauro, R.; Verde, P., An autoregulatory loop mediated by miR-21 and P.CD4 controls the AP.1 activity in RAS transformation. Oncogene, 2009, 28, (1), 73-84.
50. Göke, R., The tumour suppressor P.cd4: recent advances in the elucidation of function and regulation. Biol. Cell, 2009, 101, (6), 309-317.
51. Moghaddam, S.M.; Amini, A.; Wei, A.-Q.; P.urgholami, M.H.; Morris, D.L., Initial report on differential expression of sprouty proteins 1 and 2 in human epithelial ovarian cancer cell lines. J. Oncology, 2012, 2012.
52. Fong, C.W.; Chua, M.-S.; McKie, A.B.; Ling, S.H.M.; Mason, V.; Li, R.; Yusoff, P.; Lo, T.L.; Leung, H.Y.; So, S.K., Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down- regulated in hepatocellular carcinoma. Cancer Res., 2006, 66, (4), 2048-2058.
53. Masoumi-Moghaddam, S.; Amini, A.; Morris, D.L., The developing story of Sprouty and cancer. Cancer and Metastasis Reviews, 2014, 1-26.
54. Lee, C.-C.; P.tnam, A.J.; Miranti, C.K.; Gustafson, M.; Wang, L.- M.; Woude, G.F.V.; Gao, C.-F., Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis. Oncogene, 2004, 23, (30), 5193-5202.
55. Butz, H.; Rácz, K.; Hunyady, L.; P.tócs, A., Crosstalk between TGF-β signaling and the microRNA machinery. Trends P.armacol. Sci., 2012, 33, (7), 382-393.
56. Liu, W.H.; Yeh, S.H.; Lu, C.C.; Yu, S.L.; Chen, H.Y.; Lin, C.Y.; Chen, D.S.; Chen, P.J., MicroRNA-18a prevents estrogen receptor- α expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology, 2009, 136, (2), 683-693.
57. Kalluri, R.; Weinberg, R.A., The basics of epithelial-mesenchymal transition. J. Clin. Investig., 2009, 119, (6), 1420.
58. Thiery, J.P., Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2002, 2, (6), 442-454.
59. Burk, U.; Schubert, J.; Wellner, U.; Schmalhofer, O.; Vincan, E.; Spaderna, S.; Brabletz, T., A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports, 2008, 9, (6), 582-589.
60. Ikushima, H.; Miyazono, K., TGFβ signalling: a complex web in cancer progression. Nat. Rev. Cancer, 2010, 10, (6), 415-424.
61. Xia, M.; Hu, M., The role of microRNA in tumor invasion and metastasis. J. Cancer Mol., 2010, 5, 33-39.
62. Xia, H.; Ooi, L.L.P.; Hui, K.M., MicroRNA-216a/217-induced epithelial-mesenchymal transition targets P.EN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology, 2013, 58, (2), 629-641.
63. Shen, G.; Lin, Y.; Yang, X.; Zhang, J.; Xu, Z.; Jia, H., MicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP.X. BMC Cancer, 2014, 14, (1), 393.
64. Marquez, R.T.; Bandyopadhyay, S.; Wendlandt, E.B.; Keck, K.; Hoffer, B.A.; Icardi, M.S.; Christensen, R.N.; Schmidt, W.N.; McCaffrey, A.P., Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab. Investigation, 2010, 90, (12), 1727-1736.
65. Li, Y.; Tan, W.; Neo, T.W.; Aung, M.O.; Wasser, S.; Lim, S.G.; Tan, T., Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci., 2009, 100, (7), 1234-1242.
66. He, L.; He, X.; Lim, L.P.; De Stanchina, E.; Xuan, Z.; Liang, Y.; Xue, W.; Zender, L.; Magnus, J.; Ridzon, D., A microRNA component of the p53 tumour suppressor network. Nature, 2007, 447, (7148), 1130-1134.
67. Cole, K.A.; Attiyeh, E.F.; Mosse, Y.P.; Laquaglia, M.J.; Diskin, S.J.; Brodeur, G.M.; Maris, J.M., A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Molecular Cancer Research, 2008, 6, (5), 735-742.
68. Wong, Q.W.L.; Lung, R.W.M.; Law, P.T.Y.; Lai, P.B.S.; Chan, K.Y.Y.; To, K.F.; Wong, N., MicroRNA-223 is Commonly Repressed in Hepatocellular Carcinoma and P.tentiates Expression of Stathmin1. Gastroenterology, 2008, 135, (1), 257-269.
69. Wang, X.; Chen, Y.; Han, Q.B.; Chan, C.Y.; Wang, H.; Liu, Z.; Cheng, C.H.K.; Yew, D.T.; Lin, M.; He, M.L., P.oteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. P.oteomics, 2009, 9, (2), 242-253.
70. Datta, J.; Kutay, H.; Nasser, M.W.; Nuovo, G.J.; Wang, B.; Majumder, S.; Liu, C.-G.; Volinia, S.; Croce, C.M.; Schmittgen, T.D., Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res., 2008, 68, (13), 5049-5058.
71. Ke, B.; Shen, X.-D.; Ji, H.; Kamo, N.; Gao, F.; Freitas, M.C.S.; Busuttil, R.W.; Kupiec-Weglinski, J.W., HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: Regulation of TLR4 innate responses through P.3K/P.EN signaling. J. Hepatol., 2012, 56, (2), 359-366.
72. Salas-P.amp;#x00E9;rez, F.; Codner, E.; Valencia, E.; P.zarro, C.; Carrasco, E.; P.amp;#x00E9;rez-Bravo, F., MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (P.MCs) from patients with type 1 diabetes. Immunobiology, 2013, 218, (5), 733-737.
73. Ling, H.; Fabbri, M.; Calin, G.A., MicroRNAs and other non- coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov., 2013, 12, (11), 847-865.
74. Vasudevan, S.; Tong, Y.; Steitz, J.A., Switching from repression to activation: microRNAs can up-regulate translation. Science, 2007, 318, (5858), 1931-1934.
75. Eiring, A.M.; Harb, J.G.; Neviani, P.; Garton, C.; Oaks, J.J.; Spizzo, R.; Liu, S.; Schwind, S.; Santhanam, R.; Hickey, C.J., miR-328 functions as an RNA decoy to modulate hnRNP.E2 regulation of mRNA translation in leukemic blasts. Cell, 2010, 140, (5), 652-665.
76. Ørom, U.A.; Nielsen, F.C.; Lund, A.H., MicroRNA-10a binds the 5′ UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell, 2008, 30, (4), 460-471.
77. Mitchell, P.S.; P.rkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; P.gosova-Agadjanyan, E.L.; P.terson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A., Circulating microRNAs as stable blood-based markers for cancer detection. P.oceed. Nat Acad. Sci. U.S.A., 2008, 105, (30), 10513-10518.
78. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136, (2), 215-233.
79. Chen, Q.; Wang, H.; Liu, Y.; Song, Y.; Lai, L.; Han, Q.; Cao, X.; Wang, Q., Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3. P.os One, 2012, 7, (8), e42971.
80. Hatziapostolou, M.; P.lytarchou, C.; Aggelidou, E.; Drakaki, A.; P.ultsides, G.A.; Jaeger, S.A.; Ogata, H.; Karin, M.; Struhl, K.; Hadzopoulou-Cladaras, M., An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell, 2011, 147, (6), 1233-1247.
81. Selbach, M.; Schwanhäusser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N., Widespread changes in protein synthesis induced by microRNAs. Nature, 2008, 455, (7209), 58-63.
82. Si-Tayeb, K.; Lemaigre, F.P.; Duncan, S.A., Organogenesis and development of the liver. Develop. Cell, 2010, 18, (2), 175-189.
83. Krützfeldt, J.; Stoffel, M., MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metabolism, 2006, 4, (1), 9-12.
84. Ji, J.; Yamashita, T.; Budhu, A.; Forgues, M.; Jia, H.L.; Li, C.; Deng, C.; Wauthier, E.; Reid, L.M.; Ye, Q.H., Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology, 2009, 50, (2), 472-480.
85. Roderburg, C.; Luedde, M.; Vargas Cardenas, D.; Vucur, M.; Mollnow, T.; Zimmermann, H.W.; Koch, A.; Hellerbrand, C.; Weiskirchen, R.; Frey, N., miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J. Hepatology, 2013, 58, (4), 736-742.
86. Roderburg, C.; Urban, G.W.; Bettermann, K.; Vucur, M.; Zimmermann, H.; Schmidt, S.; Janssen, J.; Koppe, C.; Knolle, P.; Castoldi, M., Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology, 2011, 53, (1), 209-218.
87. Ogawa, T.; Enomoto, M.; Fujii, H.; Sekiya, Y.; Yoshizato, K.; Ikeda, K.; Kawada, N., MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut, 2012, 61, (11), 1600-1609.
88. Lakner, A.M.; Steuerwald, N.M.; Walling, T.L.; Ghosh, S.; Li, T.; McKillop, I.H.; Russo, M.W.; Bonkovsky, H.L.; Schrum, L.W., Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology, 2012, 56, (1), 300-310.
89. Iizuka, M.; Ogawa, T.; Enomoto, M.; Motoyama, H.; Yoshizato, K.; Ikeda, K.; Kawada, N., Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair, 2012, 5, (1), 12.
90. He, Y.; Huang, C.; Sun, X.; Long, X.-R.; Lv, X.-W.; Li, J., MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell. Signalling, 2012, 24, (10), 1923-1930.
91. Meng, Z.; Fu, X.; Chen, X.; Zeng, S.; Tian, Y.; Jove, R.; Xu, R.; Huang, W., miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology, 2010, 52, (6), 2148-2157.
92. Zheng, J.; Lin, Z.; Dong, P.; Lu, Z.; Gao, S.; Chen, X.; Wu, C.; Yu, F., Activation of hepatic stellate cells is suppressed by microRNA-150. Int. J. Mol. Med., 2013, 32, (1), 17-24.
93. Chen, C.; Wu, C.-Q.; Zhang, Z.-Q.; Yao, D.-K.; Zhu, L., Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Experiment. Cell Res., 2011, 317, (12), 1714-1725.
94. Bala, S.; Marcos, M.; Kodys, K.; Csak, T.; Catalano, D.; Mandrekar, P.; Szabo, G., Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor α (TNFα) production via increased mRNA half-life in alcoholic liver disease. J. Biol. Chem., 2011, 286, (2), 1436-1444.
95. Cermelli, S.; Ruggieri, A.; Marrero, J.A.; Ioannou, G.N.; Beretta, L., Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. P.oS One, 2011, 6, (8), e23937.
96. Gui, J.; Tian, Y.; Wen, X.; Zhang, W.; Zhang, P.; Gao, J.; Run, W.; Tian, L.; Jia, X.; Gao, Y., Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin. Sci., 2011, 120, 183-193.
97. Wei, Y.-F.; Cui, G.-Y.; Ye, P.; Chen, J.-N.; Diao, H.-Y., MicroRNAs may solve the mystery of chronic hepatitis B virus infection. World J. Gastroenterol. WJG, 2013, 19, (30), 4867.
98. Kong, G.; Zhang, J.; Zhang, S.; Shan, C.; Ye, L.; Zhang, X., Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting P.EN in cell culture model. P.oS One, 2011, 6, (5), e19518.
99. Tili, E.; Michaille, J.-J.; Liu, C.-G.; Alder, H.; Taccioli, C.; Volinia, S.; Calin, G.A.; Croce, C.M., GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res., 2010, 38, (21), 7673-7688.
100. Wang, B.; Hsu, S.-H.; Majumder, S.; Kutay, H.; Huang, W.; Jacob, S.T.; Ghoshal, K., TGFβ-mediated upregulation of hepatic miR- 181b promotes hepatocarcinogenesis by targeting TIMP.. Oncogene, 2009, 29, (12), 1787-1797.
101. Yu, Y.; Kanwar, S.S.; P.tel, B.B.; Oh, P.-S.; Nautiyal, J.; Sarkar, F.H.; Majumdar, A.P., MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis, 2012, 33, (1), 68-76.
102. He, X.; Chang, Y.; Meng, F.; Wang, M.; Xie, Q.; Tang, F.; Li, P.; Song, Y.; Lin, J., MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene, 2012, 31, (28), 3357-3369.
103. Duan, X.; Hu, J.; Wang, Y.; Gao, J.; P.ng, D.; Xia, L., MicroRNA- 145: a promising biomarker for hepatocellular carcinoma (HCC). Gene, 2014, 541, (1), 67-68.
104. Zhang, J.; Yang, Y.; Yang, T.; Liu, Y.; Li, A.; Fu, S.; Wu, M.; P.n, Z.; Zhou, W., microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer, 2010, 103, (8), 1215-1220.
105. Zhang, S.; Shan, C.; Kong, G.; Du, Y.; Ye, L.; Zhang, X., MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Oncogene, 2012, 31, (31), 3607-3620.
106. Su, H.; Yang, J.-R.; Xu, T.; Huang, J.; Xu, L.; Yuan, Y.; Zhuang, S.-M., MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res., 2009, 69, (3), 1135-1142.
107. Xiong, Y.; Fang, J.H.; Yun, J.P.; Yang, J.; Zhang, Y.; Jia, W.H.; Zhuang, S.M., Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology, 2010, 51, (3), 836-845.
108. Xu, T.; Zhu, Y.; Xiong, Y.; Ge, Y.Y.; Yun, J.P.; Zhuang, S.M., MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology, 2009, 50, (1), 113-121.
109. Andrieu, N.A.; Motino, O.; Mayoral, R.; Izquierdo, C.L.; Fernandez-Alvarez, A.; Bosca, L.; Casado, M.; Martín-Sanz, P., Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells. P.oS One, 2012, 7, (11), e50935.
110. BAO, L.-L.; Yan, Y.; JI, W.-D.; Shen, S.-W.; WU, M.-C.; SU, C.-Q., Effect of miR-21 on the proliferation and migration of human hepatoma BEL-7402 cells through AKT/ERK pathway. TUMOR, 2013, 33, (11), 947-953.
111. Lu, Y.; Yue, X.; Cui, Y.; Zhang, J.; Wang, K., MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Biochem. Biophys. Res. Communicat., 2013, 441, (4), 873-879.
112. Xing, A.-Y.; Wang, B.; Shi, D.-B.; Zhang, X.-F.; Gao, C.; He, X.- Q.; Liu, W.-J.; Gao, P., Deregulated expression of miR-145 in manifold human cancer cells. Experiment. Mol. P.thol., 2013, 95, (1), 91-97.
113. Law, P.T.-Y.; Ching, A.K.-K.; Chan, A.W.-H.; Wong, Q.W.-L.; Wong, C.-K.; To, K.-F.; Wong, N., MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Carcinogenesis, 2012, 33, (6), 1134-1141.
114. Xia, H.; Ooi, L.L.P.; Hui, K.M., MiR-214 targets β -catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. P.oS One, 2012, 7, (9), e44206.
115. Wong, Q.W.; Ching, A.K.; Chan, A.W.; Choy, K.-W.; To, K.-F.; Lai, P.B.; Wong, N., MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin. Cancer Res., 2010, 16, (3), 867-875.
116. Buurman, R.; Gürlevik, E.; Schäffer, V.; Eilers, M.; Sandbothe, M.; Kreipe, H.; Wilkens, L.; Schlegelberger, B.; Kühnel, F.; Skawran, B., Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology, 2012, 143, (3), 811-820.
117. Karakatsanis, A.; P.paconstantinou, I.; Gazouli, M.; Lyberopoulou, A.; P.lymeneas, G.; Voros, D., Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol. Carcinogenesis, 2011.
118. P.neau, P.; Volinia, S.; McJunkin, K.; Marchio, A.; Battiston, C.; Terris, B.; Mazzaferro, V.; Lowe, S.W.; Croce, C.M.; Dejean, A., miR-221 overexpression contributes to liver tumorigenesis. P.oceed. Nat Acad. Sci. U.S.A., 2010, 107, (1), 264-269.
119. Xu, J.; Wu, C.; Che, X.; Wang, L.; Yu, D.; Zhang, T.; Huang, L.; Li, H.; Tan, W.; Wang, C., Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol. Carcinogenesis, 2011, 50, (2), 136-142.
120. Xu, G.; Zhang, Y.; Wei, J.; Jia, W.; Ge, Z.; Zhang, Z.; Liu, X., MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. BMC Cancer, 2013, 13, (1), 469.
121. Zhu, M.; Wang, N.; Tsao, S.-W.; Yuen, M.-F.; Feng, Y.; Wan, T.S.; Man, K.; Feng, Y., Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Experiment. Therapeut. Med., 2011, 2, (1), 27-32.
122. Hou, J.; Lin, L.; Zhou, W.; Wang, Z.; Ding, G.; Dong, Q.; Qin, L.; Wu, X.; Zheng, Y.; Yang, Y., Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 2011, 19, (2), 232-243.
123. Huang, S.; He, X.; Ding, J.; Liang, L.; Zhao, Y.; Zhang, Z.; Yao, X.; P.n, Z.; Zhang, P.; Li, J., Upregulation of miR-23a∼ 27a∼ 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer, 2008, 123, (4), 972-978.
124. P.trocca, F.; Vecchione, A.; Croce, C.M., Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor β signaling. Cancer Res., 2008, 68, (20), 8191-8194.
125. Zhang, H.; Ozaki, I.; Mizuta, T.; Hamajima, H.; Yasutake, T.; Eguchi, Y.; Ideguchi, H.; Yamamoto, K.; Matsuhashi, S., Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma. Oncogene, 2006, 25, (45), 6101-6112.
126. Harazono, Y.; Muramatsu, T.; Endo, H.; Uzawa, N.; Kawano, T.; Harada, K.; Inazawa, J.; Kozaki, K.-i., miR-655 Is an EMT-suppressive MicroRNA targeting ZEB1 and TGFBR2. P.oS One, 2013, 8, (5), e62757.
127. Jiang, X.; Xiang, G.; Wang, Y.; Zhang, L.; Yang, X.; Cao, L.; P.ng, H.; Xue, P.; Chen, D., MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII. Mol. Cells, 2012, 33, (6), 545-551.
128. Yang, H.; Fang, F.; Chang, R.; Yang, L., MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology, 2013, 58, (1), 205-217.
129. Wei, W.; Hou, J.; Alder, O.; Ye, X.; Lee, S.; Cullum, R.; Chu, A.; Zhao, Y.; Warner, S.M.; Knight, D.A., Genome-wide microRNA and messenger RNA profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling. Hepatology, 2013, 57, (6), 2491-2501.
130. Yang, Z.; Zhang, Y.; Wang, L., A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP.3. P.oS One, 2013, 8, (6), e65256.
131. Kato, M.; P.tta, S.; Wang, M.; Yuan, H.; Lanting, L.; Nair, I.; Gunn, A.; Nakagawa, Y.; Shimano, H.; Todorov, I., TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting P.EN. Nat.Cell Biol., 2009, 11, (7), 881-889.
132. He, S.; Liu, X.; Yang, Y.; Huang, W.; Xu, S.; Yang, S.; Zhang, X.; Roberts, M., Mechanisms of transforming growth factor β1/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br. J. Dermatol., 2010, 162, (3), 538-546.
133. Liu, X.; Yang, Y.; Zhang, X.; Xu, S.; He, S.; Huang, W.; Roberts, M.S., Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-β/Smad in HepG2 cell. J. Gastroenterol. Hepatol., 2010, 25, (2), 420-426.
134. Rui, W.; Xie, L.; Liu, X.; He, S.; Wu, C.; Zhang, X.; Zhang, L.; Yang, Y., Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and P.I-1 mRNA transcription. J. Ethnopharmacology, 2014, 151, (1), 198-209.
135. Shi, Y.; Massagué, J., Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell, 2003, 113, (6), 685-700.
136. Schmierer, B.; Hill, C.S., TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol., 2007, 8, (12), 970-982.
137. Yu, B.; Bi, L.; Zheng, B.; Ji, L.; Chevalier, D.; Agarwal, M.; Ramachandran, V.; Li, W.; Lagrange, T.; Walker, J.C., The FHA domain proteins DAWDLE in Arabidopsis and SNIP. in humans act in small RNA biogenesis. P.oceed. Nat Acad. Sci. U.S.A., 2008, 105, (29), 10073-10078.
138. Hata, A.; Davis, B.N. In Regulation of microRNAs; Springer, 2010, pp 15-27.
139. Li, Q.; Wang, G.; Shan, J.L.; Yang, Z.X.; Wang, H.Z.; Feng, J.; Zhen, J.J.; Chen, C.; Zhang, Z.M.; Xu, W., MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J. Gastroenterol. Hepatology, 2010, 25, (1), 164-171.
140. Wang, Y.; Ren, J.; Gao, Y.; Ma, J.Z.; Toh, H.C.; Chow, P.; Chung, A.Y.; Ooi, L.L.; Lee, C.G., MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival. P.oS One, 2013, 8, (7), e68744.
141. Kretzschmar, M.; Doody, J.; Timokhina, I.; Massagué, J., A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Gen. Development, 1999, 13, (7), 804-816.
142. Zhao, L.; Bode, A.M.; Cao, Y.; Dong, Z., Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis, 2012, 33, (11), 2220-2227.
143. Song, M.-K.; P.rk, Y.-K.; Ryu, J.-C., P.lycyclic aromatic hydrocarbon (P.H)-mediated upregulation of hepatic microRNA- 181 family promotes cancer cell migration by targeting MAP. phosphatase-5, regulating the activation of p38 MAP.. Toxicol. Appl. P.armacol., 2013, 273, (1), 130-139.
144. Hui, L.; Zatloukal, K.; Scheuch, H.; Stepniak, E.; Wagner, E.F., P.oliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J. Clin. Investigation, 2008, 118, (12), 3943.
145. Sakurai, T.; Maeda, S.; Chang, L.; Karin, M., Loss of hepatic NF- κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. P.oceed. Nat. Acad. Sci., 2006, 103, (28), 10544-10551.
146. Kutay, H.; Bai, S.; Datta, J.; Motiwala, T.; P.gribny, I.; Frankel, W.; Jacob, S.T.; Ghoshal, K., Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem., 2006, 99, (3), 671-678.
147. Cabrita, M.A.; Christofori, G., Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis, 2008, 11, (1), 53-62.
148. Das, M.; Garlick, D.S.; Greiner, D.L.; Davis, R.J., The role of JNK in the development of hepatocellular carcinoma. Gen. Development, 2011, 25, (6), 634-645.
149. Davies, M.; Robinson, M.; Smith, E.; Huntley, S.; P.ime, S.; P.terson, I., Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAP., Smad and AP.amp;#x002D;1 signalling pathways. J. Cell. Biochem., 2005, 95, (5), 918-931.
150. Zhang, Y.E., Non-Smad pathways in TGF-β signaling. Cell Res., 2009, 19, (1), 128-139.
151. Javelaud, D.; Mauviel, A., Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene, 2005, 24, (37), 5742-5750.
152. Xu, J.; Lamouille, S.; Derynck, R., TGF-β-induced epithelial to mesenchymal transition. Cell Res., 2009, 19, (2), 156-172.
153. Vinciguerra, M.; Sgroi, A.; Buhler, L.H.; Foti, M., Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (P.EN) via microRNA-21 up-regulation in hepatocytes. Hepatology, 2009, 49, (4), 1176-1184.
154. Garofalo, M.; Di Leva, G.; Romano, G.; Nuovo, G.; Suh, S.-S.; Ngankeu, A.; Taccioli, C.; P.chiorri, F.; Alder, H.; Secchiero, P., miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through P.EN and TIMP. Downregulation. Cancer Cell, 2009, 16, (6), 498-509.
155. Esquela-Kerscher, A.; Slack, F.J., Oncomirs—microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6, (4), 259-269.
156. Calin, G.A.; Croce, C.M., MicroRNA-cancer connection: the beginning of a new tale. Cancer Res., 2006, 66, (15), 7390-7394.
157. Calin, G.A.; Sevignani, C.; Dumitru, C.D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. P.oceed. Nat. Acad. Sci. U.S.A., 2004, 101, (9), 2999-3004.
158. Cummins, J.; Velculescu, V., Implications of micro-RNA profiling for cancer diagnosis. Oncogene, 2006, 25, (46), 6220-6227.
159. Garzon, R.; Calin, G.A.; Croce, C.M., MicroRNAs in cancer. Ann. Rev. Med., 2009, 60, 167-179.
160. Ladeiro, Y.; Couchy, G.; Balabaud, C.; P.lletier, L.; Rebouissou, S.; MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 2008, 47, (6), 1955-1963.
161. Galm, O.; Herman, J.G.; Baylin, S.B., The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev., 2006, 20, (1), 1-13.
162. Ji, J.; Shi, J.; Budhu, A.; Yu, Z.; Forgues, M.; Roessler, S.; Ambs, S.; Chen, Y.; Meltzer, P.S.; Croce, C.M., MicroRNA expression, survival, and response to interferon in liver cancer. New Eng. J. Med., 2009, 361, (15), 1437-1447.
163. Chen, L.; Zheng, J.; Zhang, Y.; Yang, L.; Wang, J.; Ni, J.; Cui, D.; Yu, C.; Cai, Z., Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin- dependent and-independent pathways. Mol. Therapy, 2011, 19, (8), 1521-1528.
164. Felli, N.; Fontana, L.; P.losi, E.; Botta, R.; Bonci, D.; Facchiano, F.; Liuzzi, F.; Lulli, V.; Morsilli, O.; Santoro, S., MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. P.oceed. Nat. Acad. Sci. U.S.A., 2005, 102, (50), 18081-18086.
165. Melgert, B.N.; Olinga, P.; Van Der Laan, J.; Weert, B.; Cho, J.; Schuppan, D.; Groothuis, G.M.; Meijer, D.K.; P.elstra, K., Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology, 2001, 34, (4), 719-728.
166. Unfried, K.; Albrecht, C.; Klotz, L.-O.; Von Mikecz, A.; Grether- Beck, S.; Schins, R.P., Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology, 2007, 1, (1), 52-71.
167. Zhao, X.; Li, H.; Lee, R.J., Targeted drug delivery via folate receptors. Expert Opin. Drug Deliv., 2008, 5, 309-319.
168. Nanji, A.A.; Miao, L.; Thomas, P.; Rahemtulla, A.; Khwaja, S.; Zhao, S.; P.ters, D.; Tahan, S.R.; Dannenberg, A.J., Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology, 1997, 112, (3), 943-951.